Mabthera and haemoglobin decreased Patient Reports February 12, 2012

Mabthera Side Effects Report #4954448-7
Mabthera side effect was reported by a Physician from FRANCE on Mar 10, 2006. Female patient, 52 years of age, weighting 125.7 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: arthralgia, chest x-ray abnormal, cough, haemoglobin decreased, lung disorder, neutropenia, polyarthritis, viral infection

. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, CORTICOID, ZELITREX, CONDROSULF, OROCAL, DOLIPRANE, PENTACARINATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4625799-0
Mabthera side effect was reported by a Physician from on Mar 18, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, white blood cell count decreased, white blood cell count increased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4704615-2
Mabthera side effect was reported by a Health Professional from on June 20, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON, RULIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4712847-2
Mabthera side effect was reported by a Physician from AUSTRALIA on June 20, 2005. Male patient, 61 years of age, weighting 132.3 lb, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Mabthera. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, haemoglobin decreased, white blood cell count decreased, white blood cell count increased. Mabthera dosage: 700 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, ZANTAC, ALLOPURINOL, MAXOLON, RULIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5013939-3
Mabthera side effect was reported by a Physician from GERMANY on May 12, 2006. Male patient, 75 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: crohn's disease

, diverticulum, gastrointestinal disorder, gastrointestinal haemorrhage, haematochezia, haemoglobin decreased, haemorrhoids, ileitis. Mabthera dosage: 675 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4932240-7
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Feb 15, 2006. Male patient, 72 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, white blood cell count decreased. Mabthera dosage: 250 MG/M2, INTRAVENOUS. During the same period patient was treated with ZEVALIN, CLADRIBINE, MITOXANTRONE. Patient recovered.

Mabthera Side Effects Report #4819041-5
Mabthera side effect was reported by a Health Professional from POLAND on Oct 17, 2005. Male patient, 70 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatinine increased, haemoglobin decreased, ileus paralytic, large intestinal obstruction, platelet count decreased, pneumonia

, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG, QD, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Mabthera Side Effects Report #4825018-6
Mabthera side effect was reported by a Health Professional from POLAND on Oct 27, 2005. Male patient, 70 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatinine increased, haemoglobin decreased, ileus paralytic, platelet count decreased, pneumonia

, septic shock. Mabthera dosage: 700 MG, QD, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, ADRIAMYCIN PFS, PREDNISONE. Patient was hospitalized and became disabled. Patient recovered.

Mabthera Side Effects Report #5028023-2
Mabthera side effect was reported by a Health Professional from SPAIN on Apr 07, 2006. Female patient, 68 years of age, weighting 110.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased. Mabthera dosage: 375 MG/M2, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ADRIAMYCIN PFS, VINCRISTINE, PREDNISONE, NEORECORMON, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060296-2
Mabthera side effect was reported by a Physician from SPAIN on July 12, 2006. Female patient, 66 years of age, weighting 153.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, staphylococcal infection

. Mabthera dosage: 375 MG/M2, Q3W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, SEPTRINTE, CITALOPRAM HYDROBROMIDE, ORPHOL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5091713-X
Mabthera side effect was reported by a Physician from SWEDEN on Aug 16, 2006. Female patient, 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumocystis jiroveci pneumonia, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4772999-5
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Sept 06, 2005. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 386 MG, INTRAVENOUS. During the same period patient was treated with IBRITUMOMAB TIUXETAN, BLOPRESS, ADONA, YTTRIUM CHLORIDE HEXAHYDRATE, INDIUM TRICHLORIDE, MUCOSTA, HICEE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4905311-9
Mabthera side effect was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2006. Female patient, 58 years of age, weighting 121.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, haematocrit decreased, haemoglobin decreased, neutrophil count decreased, petechiae, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 386 MG, INTRAVENOUS. During the same period patient was treated with IBRITUMOMAB TIUXETAN, YTTRIUM CHLORIDE HEXAHYDRATE, INDIUM TRICHLORIDE, BLOPRESS, ADONA, MUCOSTA, HICEE, CIPROXIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4654113-X
Mabthera side effect was reported by a Health Professional from on Apr 25, 2005. Male patient, 57 years of age, weighting 191.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, malaise. Mabthera dosage: 800 MG, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4920113-5
Mabthera side effect was reported by a Physician from GERMANY on Feb 06, 2006. Female patient, 43 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, c-reactive protein increased, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOSORUBICIN, VINCRISTINE, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #4564070-2
Mabthera side effect was reported by a Physician from on Jan 14, 2005. Female patient, 26 years of age, weighting 99.21 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, haematotoxicity, haemoglobin decreased, platelet count decreased, skin toxicity, white blood cell count decreased. Mabthera dosage: 500 MG, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, ETOPOSIDE, CYCLOPHOSPHAMIDE, ADRIABLASTINE, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4737407-9
Mabthera side effect was reported by a Physician from BELGIUM on July 18, 2005. Male patient, 62 years of age, weighting 154.3 lb, was diagnosed with mantle cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: abdominal pain

, acute respiratory distress syndrome, blood creatine increased, blood glucose increased, blood urea increased, haematocrit decreased, haemoglobin decreased, hepatitis

, herpes zoster. Mabthera dosage: unknown. Patient died on 06/21/2005.

Mabthera Side Effects Report #4750039-1
Mabthera side effect was reported by a Physician from FRANCE on Aug 09, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, CORTANCYL, ADRIABLASTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4754791-0
Mabthera side effect was reported by a Physician from FRANCE on Aug 16, 2005. Male patient, 71 years of age, weighting 136.7 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Mabthera dosage: 630 MG, QD, INTRAVENOUS. During the same period patient was treated with ONCOVIN, CYCLOPHOSPHAMIDE, PREDNISONE, ADRIABLASTINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5052940-0
Mabthera side effect was reported by a Health Professional from SPAIN on June 29, 2006. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased. Mabthera dosage: 375 MG/M2, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5281131-3
Mabthera side effect was reported by a Physician from CZECH REPUBLIC on Mar 12, 2007. Female patient, 60 years of age, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: encephalopathy, haemoglobin decreased, neuropathy peripheral, neurotoxicity, platelet count decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, CYTARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5048834-7
Mabthera side effect was reported by a Physician from UNITED KINGDOM on June 26, 2006. Female patient, 47 years of age, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hypoxia, international normalised ratio increased, lung consolidation, pneumonia

, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUCONAZOLE, ACYCLOVIR, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 03/04/2005.

Mabthera Side Effects Report #4625742-4
Mabthera side effect was reported by a Physician from on Mar 15, 2005. Female patient, 47 years of age, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood immunoglobulin a decreased, blood immunoglobulin m decreased, chest pain

, dyspnoea, haemoglobin decreased, lung consolidation, neutrophil count abnormal, pneumonia

, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUCONAZOLE, ACICLOVIR, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 03/04/2005.

Mabthera Side Effects Report #5117914-X
Mabthera side effect was reported by a Health Professional from GERMANY on Sept 13, 2006. Female patient, weighting 143.3 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: candidiasis, condition aggravated, haematocrit decreased, haemoglobin decreased, mucosal inflammation, oral intake reduced. Mabthera dosage: 645 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, PANTOPRAZOLE. Patient was hospitalized. Patient died on 08/28/2006.

Mabthera Side Effects Report #5122741-3
Mabthera side effect was reported by a Physician from GERMANY on Sept 26, 2006. Female patient, weighting 143.3 lb, was diagnosed with lymphoma

and was treated with Mabthera. After drug was administered, patient experienced the following side effects: candidiasis, haematocrit decreased, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: 645 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, PANTOPRAZOLE. Patient was hospitalized. Patient died on 08/28/2006.

Mabthera Side Effects Report #5036709-9
Mabthera side effect was reported by a Physician from NETHERLANDS on June 13, 2006. Female patient, 80 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, haemoglobin decreased. Mabthera dosage: 375 MG/M2. Patient recovered.

Mabthera Side Effects Report #5064910-7
Mabthera side effect was reported by a Physician from NETHERLANDS on July 20, 2006. Female patient, 78 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, haemoglobin decreased. Mabthera dosage: 375 MG/M2. Patient recovered.

Mabthera Side Effects Report #4644290-9
Mabthera side effect was reported by a Physician from on Apr 13, 2005. Male patient, 79 years of age, weighting 152.1 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, blood lactate dehydrogenase increased, c-reactive protein increased, haemoglobin decreased, platelet count decreased, pneumonia

, respiratory failure, septic shock, ventricular fibrillation. Mabthera dosage: 375 MG/M2. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, DISALUNIL, BISOPROLOL, TAMSULOSIN, ATORVASTATIN. Patient was hospitalized. Patient died.

Mabthera Side Effects Report #4685154-4
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, 69 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased. Mabthera dosage: 680 MG, Q14D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, VINCRISTINE, PREDNISONE, NEXIUM, LOCOL, ALLOPURINOL, BELOC. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5035191-5
Mabthera side effect was reported by a Physician from GERMANY on June 20, 2006. Male patient, 69 years of age, weighting 154.3 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: catheter related infection, febrile neutropenia, haemoglobin decreased, klebsiella infection, sepsis

. Mabthera dosage: 680 MG, Q14D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEXIUM, LOCOL, ALLOPURINOL, BELOC. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5281330-0
Mabthera side effect was reported by a Physician from SWITZERLAND on Mar 14, 2007. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, multi-organ failure, platelet count decreased, septic shock, white blood cell count decreased. Mabthera dosage: 700 MG. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient died on 09/01/2005.

Mabthera Side Effects Report #4649841-6
Mabthera side effect was reported by a Physician from on Apr 18, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: c-reactive protein increased, febrile neutropenia, haemoglobin decreased, humerus fracture, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, CYTARABINE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4776604-3
Mabthera side effect was reported by a Health Professional from SWITZERLAND on Sept 05, 2005. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematotoxicity, haemoglobin decreased, infection

, laboratory test interference, septic shock, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4569737-8
Mabthera side effect was reported by a Consumer or non-health professional from on Jan 18, 2005. Male patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematotoxicity, haemoglobin decreased, thrombocytopenia, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4597204-4
Mabthera side effect was reported by a Consumer or non-health professional from on Feb 17, 2005. Male patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematotoxicity, haemoglobin decreased, thrombocytopenia, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE, FILGRASTIM, FRAXIPARINE, ITRACONAZOLUM, AMOXICILLIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5269659-3
Mabthera side effect was reported by a Health Professional from IRELAND on Mar 02, 2007. Male patient, 59 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood sodium decreased, gastrointestinal toxicity, haemoglobin decreased, hyperkalaemia, pco2 decreased, renal tubular acidosis. Mabthera dosage: unknown. During the same period patient was treated with CYTARABINE, CARMUSTINE, ETOPOSIDE, MELPHALAN, ZOFRAN, ALLOPURINOL, SEPTRA. Patient recovered.

Mabthera Side Effects Report #4556918-2
Mabthera side effect was reported by a Physician from on Jan 07, 2005. Female patient, 58 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, renal failure acute. Mabthera dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYTOSINE ARABINOSIDE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4592507-1
Mabthera side effect was reported by a Physician from on Feb 08, 2005. Female patient, 58 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood magnesium decreased, haemoglobin decreased, renal failure acute. Mabthera dosage: 375 MG/M2, 1/WEEK, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CYTOSINE ARABINOSIDE, DEXAMETHASONE, VIOXX, DICLOFENAC. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4568352-X
Mabthera side effect was reported by a Physician from on Jan 18, 2005. Female patient, 53 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: asthenia, dehydration, febrile neutropenia, haemoglobin decreased, nausea

, platelet count decreased, renal impairment, white blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5030844-7
Mabthera side effect was reported by a Physician from AUSTRALIA on June 09, 2006. Male patient, 27 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased. Mabthera dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5806646-8
Mabthera side effect was reported by a Health Professional from UNITED STATES on July 01, 2008. Female patient, weighting 110.2 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, renal haemorrhage. Mabthera dosage: 375 MG/M2, Q2W. During the same period patient was treated with ENZASTAURIN, GEMCITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4669465-4
Mabthera side effect was reported by a Physician from on May 06, 2005. Female patient, 79 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, platelet count decreased, urinary tract infection

, white blood cell count decreased. Mabthera dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, PHENERGAN, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #4698401-X
Mabthera side effect was reported by a Physician from on June 16, 2005. Female patient, 79 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, neutropenia, urinary tract infection

. Mabthera dosage: 650 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, PHENERGAN, PREDNISONE. Patient recovered.

Mabthera Side Effects Report #4777108-4
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Sept 01, 2005. Male patient, 78 years of age, weighting 145.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atrial fibrillation

, dizziness

, febrile neutropenia, haemoglobin decreased, hiatus hernia, lung hyperinflation, malaise. Mabthera dosage: 670 MG, Q28D, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, OXAZEPAM, ASPIRIN, BACTRIM DS, VALACYCLOVIR, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5060285-8
Mabthera side effect was reported by a Health Professional from BELGIUM on July 05, 2006. Male patient, 71 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: abscess

, abscess bacterial, brain oedema, cerebral aspergillosis, cerebral toxoplasmosis, encephalitis herpes, haemoglobin decreased, immunodeficiency, nocardiosis. Mabthera dosage: 500 MG/M2, 1/MONTH, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4745704-6
Mabthera side effect was reported by a Health Professional from GERMANY on Aug 01, 2005. Male patient, 64 years of age, weighting 159.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atelectasis, febrile neutropenia, haemoglobin decreased, platelet count decreased, pleural effusion, pleural fibrosis, red blood cell count decreased, sepsis

. Mabthera dosage: 713 MG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, BACTRIM, ACYCLOVIR, BLOOD PRODUCTS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4774994-9
Mabthera side effect was reported by a Physician from GERMANY on Sept 09, 2005. Male patient, 64 years of age, weighting 159.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: atelectasis, body temperature increased, chills, febrile neutropenia, haemoglobin decreased, lung infiltration, platelet count decreased. Mabthera dosage: 713 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, BACTRIM, ACYCLOVIR, BLOOD PRODUCTS. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5304774-7
Mabthera side effect was reported by a Physician from GERMANY on Apr 11, 2007. Male patient, 63 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: arthralgia, borrelia burgdorferi serology negative, borrelia infection, disease progression, facial paresis, gamma-glutamyltransferase increased, haemoglobin decreased, hyperaesthesia, lymphoma

. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Mabthera Side Effects Report #4682002-3
Mabthera side effect was reported by a Physician from on May 20, 2005. Male patient, 63 years of age, weighting 213.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, neutropenia, platelet count decreased. Mabthera dosage: 840 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, BACTRIM DS. Patient recovered.

Mabthera Side Effects Report #4696099-8
Mabthera side effect was reported by a Physician from on June 03, 2005. Male patient, 63 years of age, weighting 213.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, neutropenia, platelet count decreased. Mabthera dosage: 840 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, BACTRIM DS. Patient recovered.

Mabthera Side Effects Report #5047231-8
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 16, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5055325-6
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 30, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, jc virus infection, platelet count decreased, virus urine test positive, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5085560-2
Mabthera side effect was reported by a Health Professional from AUSTRALIA on June 30, 2006. Male patient, 62 years of age, weighting 125.7 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: cystitis haemorrhagic, fluid intake reduced, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 785 MG, Q4W, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, BACTRIM, VALTREX, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4996452-9
Mabthera side effect was reported by a Physician from BELGIUM on Apr 21, 2006. Male patient, 58 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bronchopneumonia, disseminated intravascular coagulation, haematocrit decreased, haemodynamic instability, haemoglobin decreased, hypotension, hypoxia, metabolic acidosis. Mabthera dosage: 750 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, AVELOX, ZOVIRAX. Patient died on 04/09/2006.

Mabthera Side Effects Report #5084871-4
Mabthera side effect was reported by a Health Professional from GERMANY on Aug 04, 2006. Female patient, 54 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: diarrhoea, electrocardiogram t wave inversion, febrile neutropenia, haematocrit decreased, haemoglobin decreased, lymphadenopathy, white blood cell count decreased. Mabthera dosage: 375MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4757152-3
Mabthera side effect was reported by a Physician from GERMANY on Aug 15, 2005. Female patient, 54 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: diarrhoea, electrocardiogram t wave inversion, febrile neutropenia, haematocrit decreased, haemoglobin decreased, lymphadenopathy. Mabthera dosage: 375MG/M2, DAY 1, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5140716-5
Mabthera side effect was reported by a Physician from AUSTRALIA on Oct 12, 2006. Male patient, 49 years of age, weighting 176.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: blood culture positive, cellulitis

, haemoglobin decreased, immunosuppression, limb injury, malaise, osteomyelitis, pneumococcal infection, purulence. Mabthera dosage: 985 MG, Q4W, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, TEGRETOL, ATORVASTATIN, GLICLAZIDE, PIOGLITAZONE, NPH INSULIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4883255-9
Mabthera side effect was reported by a Physician from AUSTRALIA on Jan 04, 2006. Male patient, 40 years of age, weighting 169.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: ear pain, haemoglobin decreased, infection

, laboratory test abnormal, neutropenia, platelet count decreased, rash

, red blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, CHLARAXTYNE, DIFLUCAN, VALACYCLOVIR, MAXOLON, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4918169-9
Mabthera side effect was reported by a Physician from AUSTRALIA on Feb 02, 2006. Male patient, 40 years of age, weighting 169.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabthera. After drug was administered, patient experienced the following side effects: ear pain, haemoglobin decreased, infection

, neutropenia, platelet count decreased, red blood cell count decreased. Mabthera dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, DIFLUCAN, VALACYCLOVIR, MAXOLON, ALLOPURINOL, TRIMETHOPRIM. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4788891-6
Mabthera side effect was reported by a Physician from GERMANY on Sept 21, 2005. Male patient, 63 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: aplasia, blood lactate dehydrogenase increased, blood urea increased, cerebral haemorrhage, circulatory collapse, haematotoxicity, haemoglobin decreased, mucosal inflammation. Mabthera dosage: 712 MG, SINGLE. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient was hospitalized. Patient died on 09/01/2005.

Mabthera Side Effects Report #4685239-2
Mabthera side effect was reported by a Physician from on May 23, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4710582-8
Mabthera side effect was reported by a Health Professional from NEW ZEALAND on July 01, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count abnormal, white blood cell count abnormal. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4816221-X
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: unknown. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4816222-1
Mabthera side effect was reported by a Physician from NEW ZEALAND on Oct 19, 2005. Male patient, 60 years of age, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Mabthera dosage: 700 MG. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4923919-1
Mabthera side effect was reported by a Consumer or non-health professional from AUSTRALIA on Feb 06, 2006. Male patient, 59 years of age, weighting 187.4 lb, was diagnosed with b-cell lymphoma and was treated with Mabthera. After drug was administered, patient experienced the following side effects: biliary dilatation, blood urea increased, cholecystitis, cholelithiasis, febrile neutropenia, haemoglobin decreased. Mabthera dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4924480-8
Mabthera side effect was reported by a Health Professional from AUSTRALIA on Feb 14, 2006. Female patient, 75 years of age, was treated with Mabthera. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, urinary tract infection

. Mabthera dosage: 650 MG, X2, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, PHENERGAN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #4837380-9
Mabthera side effect was reported by a Physician from CHINA on Nov 07, 2005. Female patient, 58 years of age, weighting 110.2 lb, was treated with Mabthera. After drug was administered, patient experienced the following side effects: agranulocytosis, gastrointestinal ulcer, haemoglobin decreased. Mabthera dosage: 500 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with METHOTREXATE, DEXAMETHASONE, NOS, AUGMENTIN, VANCOMYCIN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Mabthera and haemoglobin decreased

SideEffects101.com

Mabthera and haemoglobin decreased Patient Reports February 12, 2012

side effects of Mabthera